Table 2.
Baseline Measurements | Measurements at completion of study | |||||||
HR | MAP | CO | NorEpi | HR | MAP | CO | NorEpi | |
1 | 103 | 96 | 8.03 | 0 | 93 | 95 | 6.04 | 0 |
2 | 85 | 119 | 9.01 | 0 | 97 | 130 | 9.06 | 0 |
3 | 101 | 69 | 4.05 | 0.02 | 106 | 77 | 6.02 | 0.02 |
4* | 116 | 82 | 10.03 | 0.06 | 103 | 80 | 10.03 | 0.06 |
5 | 129 | 118 | 8.02 | 0 | 128 | 113 | 7.07 | 0 |
6* | 121 | 80 | 14.08 | 0.01 | 118 | 85 | 15.01 | 0.01 |
7 | 68 | 85 | 2.08 | 0 | 90 | 78 | 4.01 | 0 |
8 | 118 | 79 | 8.08 | 0.02 | 71 | 99 | 5.06 | 0.02 |
9 | 82 | 100 | 3.07 | 0 | 110 | 100 | 3.06 | 0 |
10 | 117 | 66 | 18.03 | 0.02 | 109 | 70 | 14.05 | 0.02 |
11 | 115 | 80 | 4.09 | 0 | 134 | 71 | 5.03 | 0 |
12 | 99 | 66 | 6.02 | 0 | 108 | 76 | 5.00 | 0 |
13 | 105 | 64 | 5.06 | 0.03 | 110 | 72 | 4.07 | 0.03 |
14 | 89 | 83 | 6.08 | 0.01 | 83 | 84 | 5.02 | 0.01 |
HR is heart rate (/minute), MAP is mean arterial pressure (mmHg), CO is cardiac output (L/min) and NorEpi is dose of norepinephrine in mcg/kg/min. * describes the patients where the second set of measurements was taken at four hours rather than eight due to being removed from the study.